✦ LIBER ✦

Oestrogen receptor in breast cancer: prognostic studies using a new immunohistochemical assay

✍ Scribed by P.N. COWEN; J. TEASDALE; P. JACKSON; B.J. REID

Book ID: 108777950
Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 468 KB
Volume: 17
Category: Article
ISSN: 0309-0167
DOI: 10.1111/j.1365-2559.1990.tb00735.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

IMMUNOHISTOCHEMICAL ASSAY FOR OESTROGEN

IMMUNOHISTOCHEMICAL ASSAY FOR OESTROGEN RECEPTORS IN PARAFFIN WAX SECTIONS OF BREAST CARCINOMA USING A NEW MONOCLONAL ANTIBODY

✍ HUANG, AIHUA; PETTIGREW, NORMAN M.; WATSON, PETER H. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 581 KB

The aim of this study was to evaluate the utility of a new monoclonal antibody (AER311) that targets the oestrogen receptor (ER) in an immunohistochemical assay (IHA) applied to breast cancers. Ninety-seven cases of invasive ductal carcinoma were studied by AER311-IHA using a pressure-cooking antige

Development and validation of a sensitiv

Development and validation of a sensitive immunohistochemical oestrogen receptor assay for use on archival breast cancer tissue

✍ P. Jackson; J. Teasdale; P. N. Cowen 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 820 KB

The progesterone receptor has a prognost

The progesterone receptor has a prognostic value in oestrogen receptor negative breast cancers

✍ H.J Huang; P Neven; M Drijkoningen; R Paridaens; P Berteloot; F Amant; I Vergote 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 325 KB

Prognostic significance of oestrogen and

Prognostic significance of oestrogen and progestogen receptor activities in breast cancer

✍ Dr R. A. Hawkins; Gillian White; N. J. Bundred; J. M. J. Dixon; W. R. Miller; He 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

Abstract The prognostic significance of the tumour activities of 2 steroid receptors, those for oestrogen (ER) and for progestogen (PgR), has been studied in 372 patients with breast cancer, in whom follow-up was available for 2-6 years (median 41 months). Of 252 patients with operable disease, 75·8

Fluorescent cytochemical oestrogen recep

Fluorescent cytochemical oestrogen receptor assay: Is it valid in breast cancer?

✍ C. M. Furnival; K. C. Chong; L. R. Watson; A. Visona 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 368 KB

The performance of a fluorescent cytochemical oestrogen receptor (ER) assay has been compared with an established dextran-coated charcoal ER assay in 85 cases of primary breast cancer. Both assays were performed on tissue samples from the same tumour, by independent observers in different laboratori

Semiquantitative oestrogen receptor assa

Semiquantitative oestrogen receptor assay in formalin-fixed paraffin sections of human breast cancer tissue using monoclonal antibodies

✍ Andersen, J; Ørntoft, T; Poulsen, H Skovgaard 📂 Article 📅 1986 🏛 Nature Publishing Group 🌐 English ⚖ 824 KB